Fund Holdings — Logos Global Management LP

Total Portfolio Value:
$899.34M
Total Bought:
$415.62M
Total Sold:
$255.00M
Net Transaction:
+$160.62M
Notable People:
Logos Global Management Gp Llc, Arsani Hany William, Graham Gordon Walmsley
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Cytokinetics, Incorporated(CYTK)1,250,0001,625,000+375,000$36.83M$135.67M15.09%+$98.85M
IDEAYA Biosciences, Inc.(IDYA)2,250,0001,800,000-450,000$60.70M$64.04M7.12%+$3.34M
Apellis Pharmaceuticals Inc
COM
750,000950,000+200,000$28.53M$56.87M6.32%+$28.34M
argenx SEADR(ARGX)0145,000+145,000$0$55.16M6.13%+$55.16M
Olema Pharmaceuticals, Inc.(OLMA)3,743,8754,383,875+640,000$46.24M$54.38M6.05%+$8.14M
Immunovant, Inc.(IMVT)1,600,0001,200,000-400,000$61.42M$50.56M5.62%-$10.87M
Structure Therapeutics IncADS500,0001,070,058+570,058$25.21M$43.62M4.85%+$18.41M
Rocket Pharmaceuticals, Inc.(RCKT)1,975,0001,275,000-700,000$40.47M$38.21M4.25%-$2.26M
Rayzebio Inc0568,173+568,173$0$35.32M3.93%+$35.32M
Ambrx Biopharma Inc02,100,000+2,100,000$0$29.90M3.33%+$29.90M
Karuna Therapeutics Inc115,00090,000-25,000$19.45M$28.49M3.17%+$9.04M
Immunocore Holdings plcADS(IMCR)450,000400,000-50,000$23.36M$27.33M3.04%+$3.97M
Dyne Therapeutics, Inc.(DYN)2,180,0001,880,000-300,000$19.53M$25.00M2.78%+$5.47M
Annexon, Inc.(ANNX)5,300,0004,950,000-350,000$12.51M$22.47M2.50%+$9.96M
Akero Therapeutics Inc600,000800,000+200,000$30.35M$18.68M2.08%-$11.67M
Ocular Therapeutix, Inc.(OCUL)04,000,000+4,000,000$0$17.84M1.98%+$17.84M
Morphosys AgADS950,0001,475,000+525,000$6.38M$14.60M1.62%+$8.22M
Design Therapeutics, Inc.(DSGN)5,032,5015,032,5010$11.88M$13.34M1.48%+$1.46M
Viridian Therapeutics, Inc.(VRDN)1,050,000600,000-450,000$16.11M$13.07M1.45%-$3.04M
Edgewise Therapeutics, Inc.(EWTX)0950,000+950,000$0$10.39M1.16%+$10.39M
Revolution Medicines, Inc.(RVMD)250,000350,000+100,000$6.92M$10.04M1.12%+$3.12M
Acelyrin Inc01,250,000+1,250,000$0$9.32M1.04%+$9.32M
MoonLake ImmunotherapeuticsCL A(MLTX)0150,000+150,000$0$9.06M1.01%+$9.06M
Atyr Pharma Inc05,850,000+5,850,000$0$8.25M0.92%+$8.25M
Fulcrum Therapeutics, Inc.(FULC)01,200,000+1,200,000$0$8.10M0.90%+$8.10M
Allakos Inc4,650,0002,900,000-1,750,000$10.56M$7.92M0.88%-$2.64M
Tourmaline Bio Inc0284,372+284,372$0$7.44M0.83%+$7.44M
Avidity Biosciences Inc0775,000+775,000$0$7.01M0.78%+$7.01M
Silence Therapeutics plcADS(SLN)0400,000+400,000$0$6.95M0.77%+$6.95M
Xenon Pharmaceuticals Inc.(XENE)450,000150,000-300,000$15.37M$6.91M0.77%-$8.46M
Neumora Therapeutics, Inc.(NMRA)0382,345+382,345$0$6.52M0.72%+$6.52M
Arcus Biosciences, Inc.(RCUS)0325,000+325,000$0$6.21M0.69%+$6.21M
Morphic Hldg Inc0200,000+200,000$0$5.78M0.64%+$5.78M
Applied Therapeutics Inc01,660,000+1,660,000$0$5.56M0.62%+$5.56M
Ventyx Biosciences Inc225,0002,000,000+1,775,000$7.81M$4.94M0.55%-$2.87M
Icosavax Inc2,765,741300,000-2,465,741$21.43M$4.73M0.53%-$16.71M
Repare Therapeutics Inc300,000600,000+300,000$3.62M$4.38M0.49%+$756.0K
COMPASS Pathways plcADS(CMPS)950,000500,000-450,000$7.03M$4.38M0.49%-$2.65M
Enliven Therapeutics Inc307,076307,0760$4.19M$4.25M0.47%+$55.3K
Astria Therapeutics Inc544,960544,9600$4.07M$4.19M0.47%+$119.9K
Inhibrx Inc0100,000+100,000$0$3.80M0.42%+$3.80M
Spyre Therapeutics, Inc.(SYRE)210,000150,000-60,000$2.57M$3.23M0.36%+$655.5K
Kiniksa Pharmaceuticals LtdCL A0150,000+150,000$0$2.63M0.29%+$2.63M
Delcath Systems, Inc.(DCTH)1,044,444300,000-744,444$4.23M$1.25M0.14%-$2.98M
Io Biotech Inc493,827493,8270$696.3K$928.4K0.10%+$232.1K
Immunic, Inc.(IMUX)421,184421,1840$619.1K$631.8K0.07%+$12.6K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)66,66666,6660$6.7K$4.0K0.00%-$2.7K
89BIO INCCOM310,0000-310,000$4.79M$0—-$4.79M
ALX ONCOLOGY HLDGS INCCOM(ALXO)1,000,0000-1,000,000$4.80M$0—-$4.80M
AMBRX BIOPHARMA INCSPONSORED ADS115,0000-115,000$1.32M$0—-$1.32M
BRIDGEBIO PHARMA INCCOM(BBIO)400,0000-400,000$10.55M$0—-$10.55M
CEREVEL THERAPEUTICS HLDNG ICOM700,0000-700,000$15.28M$0—-$15.28M
CRINETICS PHARMACEUTICALS INCOM(CRNX)250,0000-250,000$7.43M$0—-$7.43M
GERON CORPCOM(GERN)2,750,0000-2,750,000$5.83M$0—-$5.83M
GRACELL BIOTECHNOLOGIES INCSPONSORED ADS2,525,0000-2,525,000$7.27M$0—-$7.27M
IMMATICS N.VSHS(IMTX)1,050,0000-1,050,000$12.16M$0—-$12.16M
KALVISTA PHARMACEUTICALS INCCOM900,0000-900,000$8.67M$0—-$8.67M
LEAP THERAPEUTICS INCCOM NEW(CYPH)354,2660-354,266$488.9K$0—-$488.9K
LIANBIOSPONSORED ADS(LIANY)280,0000-280,000$417.2K$0—-$417.2K
MERUS N VCOM245,0000-245,000$5.78M$0—-$5.78M
MIRATI THERAPEUTICS INCCOM300,0000-300,000$13.07M$0—-$13.07M
NEUROCRINE BIOSCIENCES INCCOM(NBIX)150,0000-150,000$16.88M$0—-$16.88M
RHYTHM PHARMACEUTICALS INCCOM(RYTM)400,0000-400,000$9.17M$0—-$9.17M
ROIVANT SCIENCES LTDSHS(ROIV)1,200,0000-1,200,000$14.02M$0—-$14.02M
SAREPTA THERAPEUTICS INCCOM(SRPT)200,0000-200,000$24.24M$0—-$24.24M
SOLENO THERAPEUTICS INCCOM125,0000-125,000$3.69M$0—-$3.69M
TYRA BIOSCIENCES INCCOM(TYRA)31,8720-31,872$438.9K$0—-$438.9K
VERVE THERAPEUTICS INCCOM215,0000-215,000$2.85M$0—-$2.85M
VIGIL NEUROSCIENCE INCCOM188,3900-188,390$1.02M$0—-$1.02M
ZURA BIO LTDCLASS A ORD SHS(ZURA)424,0000-424,000$2.80M$0—-$2.80M
Page 1 of 1
Logos Global Management LP — 13F Holdings — Q4 2023 | TickerTrail